Since AlphaGo defeated Li Shishi, the machine has never stopped to replace human beings. The extremely high medical access is once considered to be the last city that artificial intelligence is difficult to capture. However, with the rise of medical AI in China, especially in the field of medical imaging AI, this city seems to have been found to "break the mouth."
Just last week, more than a year after the release of the first intelligent diagnostic product Discover/Lung Nodule lung nodule intelligent diagnosis system, Tuma Deep has released four new smart products, namely the chest X-ray intelligent diagnosis system ( σ-Discover/Lung DR), mammography intelligent diagnostic system (σ-Discover/Mammo), stroke CT intelligent diagnosis system (σ-Discover/Stroke CT), liver CT intelligent diagnosis system (σ-Discover/Liver CT) Covers all processes such as disease surveillance, quantitative analysis, disease classification, benign and malignant judgment, follow-up and report generation.
Lu Jianping, director of the Department of Imaging Medicine of Changhai Hospital affiliated to the Naval Military Medical University, also attended the Tuma Deep Peace Conference. He believes that the current role of medical AI is mainly to reduce the burden on doctors, avoid missed diagnosis and give preliminary diagnosis. On the other hand, the greatest help for artificial intelligence in China's medical system is to empower grassroots doctors to change the current level of doctors' levels.
Tsuma’s CEO, Zhong Rong, also agreed, “health is the result of comprehensive diagnosis, and it is necessary to contact a variety of disease characteristics and backgrounds of life. Artificial intelligence has developed to more than 50 years today, still in the stage of weak artificial intelligence. It plays a role in assisting work. However, through the combination of deep learning technology and medical big data , medical imaging AI greatly improves the diagnostic efficiency and accuracy of doctors.†Tuma Deep's first product lung nodule intelligent diagnosis system released one year More than, it has covered nearly 200 hospitals, the detection rate is over 97%, and the coincidence rate between benign and malignant judgments exceeds 90%.
"Willing the difficulties" or "winning the prize"?
It is not only the first product of Tuoma Shenwei that focuses on lung nodules. Since the medical imaging AI has been booming, the lung nodule project has become the object of collective enterprise gathering, and the lung nodule project seems to be “quite well doneâ€.
Wu Gang, vice president of Tuma Deep Wei, said: "The intelligent auxiliary diagnostic products for lung nodules are actually not good, and there are very few mature products. There are very few good and bad judgments. Other products are difficult to develop, covering inspections. It is more difficult to diagnose, treat and process the entire process. This is the industry consensus."
The new products released by Tuma Deep include chest, mammography, stroke, and liver, and some of them are “welcome to the hardâ€.
However, in view of the technical accumulation and accumulation of the lung nodule project before the Tumar deep, it seems that it is not too difficult to expand the application of the multi-species scene. Zhong Rong said that by model migration learning, each product will be faster and faster. It is reported that these four new products adopt the latest methods in the field of deep learning and artificial intelligence, including deep confrontation generation network and general model training based on 3D convolution, and the same network by extracting shareable information from various data. The model is used in multiple applications at the same time, which greatly improves the efficiency of model training and calculation, and effectively solves the imbalance between medical data categories and the incomplete data annotation.
Wu Gang introduced that at present, four smart new products of Tuma Deep have been tested in hospitals. Other products such as prostate cancer, fractures, and sugar net diseases are in the research and development stage. This series of products focuses on areas with high incidence of Chinese patients such as tumors, cardiovascular and cerebrovascular diseases, and chronic diseases, and has been customized for Chinese patients. In the future, Tuma's deep-dimensional plan will quickly realize the full-process diagnostic coverage of multiple parts of the human body with the speed of releasing 3-5 new products every year, and strengthen the expansion of overseas markets such as the United States, Europe, Japan, and Southeast Asia.
Refused to build a car behind closed doors, cooperation to help the industry develop
In the current field of medical imaging AI, not only many startups are entering and expanding their product lines, including Internet giants such as Tencent and Ali, and large medical device manufacturers such as GE Healthcare, Philips, and Neusoft are also making a big push. Compared with these giant companies, do you feel the cold beam behind the startups like Tuma Deep?
Tuma’s CTO Gao Dashan believes that in terms of new disruptive technologies such as artificial intelligence, startups can do more in-depth and flexible things on “pointsâ€, deeply understand the process of doctors’ treatment, where are the pain points, and create An artificial intelligence system that is more suitable for medical development.
In dealing with these giants, Tuma's attitude is to achieve win-win cooperation. Last month, Tumar Shenwei also reached a cooperation with Ali Health and joined the Ali Health AI development platform ecosystem.
In Zhong Rong's view, whether it is Ali or Tencent, their advantage is to build a cloud platform, realize the interconnection between hospitals, and pave the highways with industrial ecology. As for the vehicles that are fully accelerated on the expressway, they are all startup companies. For traditional medical device manufacturers, their operating income mainly comes from traditional Medical Equipment . Tuma Shenwei cooperates with GE and other equipment manufacturers to help them save development costs. On the other hand, traditional equipment and artificial intelligence promote Sales of traditional equipment.
In succession, Tuma Deep maintains cooperation with head companies in many industries in product development and landing, including GE Healthcare, NVIDIA, Ali Health, Lianzhong, and Vision, to jointly accelerate China's smart health care reform. Open process.
Stomach Tube,stomach tube sizes,Feeding Tube,tube feeding
Anesthesia Medical Co., Ltd. , https://www.honestymed.com